Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea

Published:2013 Issue:4 Volume:2 Page:156
ISSN:2279-042X
Container-title:Journal of Research in Pharmacy Practice
language:en
Short-container-title:J Res Pharm Pract

Author:

Jain Parveen,Das V. N. R.,Ranjan Alok,Chaudhary Rahul,Pandey Krishna

Publisher

Medknow

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Pharmacy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities;Annals of Hematology;2024-06-05

2. Does platelet aggregation differ among chronic myeloid leukemia-chronic phase (CML-CP) patients on tyrosine kinase inhibitors (TKIs)? A tertiary center experience;The Egyptian Journal of Haematology;2023-04

3. Plasma Level of Programmed Death Receptor Ligand-1 and CD25 in Chronic Myeloid Leukemia Patients and their Correlations with Response to First-Line Therapy;Medical Journal of Babylon;2021-10

4. Variables associated with self-reported anxiety and depression symptoms in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy;Leukemia & Lymphoma;2020-11-05

5. Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review;Clinical Oral Investigations;2019-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP